Study guide
19.3 Proficiency Testing, Competency, and Accreditation
ASCP Microbiology Technologist M ASCP
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current M(ASCP) Exam Facts 1.2 CAT, Scoring, Retakes, and CMP 1.3 Eligibility Routes and Clinical Experience
2 Preanalytic: Collection and Transport
2.1 Patient Identification and Specimen Labeling 2.2 Specimen Collection, Sterile Technique, and Blood Cultures 2.3 Transport Devices, Atmosphere, Time, and Temperature
3 Preanalytic: Processing, Media, and Incubation
3.1 Prioritization, Rejection, and Specimen Preparation 3.2 Media Types, Components, and Selection 3.3 Inoculation, Incubation Conditions, and Slide Preparation
4 Preanalytic: Stains
4.1 Gram Stain: Procedure, Principle, and Interpretation 4.2 Acid-Fast and Modified Acid-Fast Stains 4.3 KOH, Calcofluor-White, Trichrome, Giemsa, and Acridine Orange
5 Bacteriology: Blood and Bone Marrow
5.1 Blood Culture Systems and Rapid Identification 5.2 Bloodstream Pathogens and Skin Flora Significance 5.3 Endocarditis, Bone Marrow Pathogens, and Pathogenicity
6 Bacteriology: CSF and Sterile Body Fluids
6.1 CSF Sources and Acute Meningitis Pathogens 6.2 Shunt Infections, CSF Correlates, Antigen and Molecular Methods 6.3 Sterile Body Fluids: Pathogens, Flora, and Molecular Methods
7 Bacteriology: Respiratory Tract
7.1 Lower Respiratory Specimens, CAP, and HAP Pathogens 7.2 Cystic Fibrosis Pathogens and Quantitative Reporting 7.3 Upper Respiratory: Pharyngitis, Otitis, Sinusitis, Antigen/Molecular
8 Bacteriology: Gastrointestinal Tract
8.1 Enteric Pathogens: Culture and Colony Morphology 8.2 Clostridioides difficile, Shiga Toxin, and Serotyping 8.3 Helicobacter pylori Detection and GI Pathogenicity
9 Bacteriology: Skin, Soft Tissue, and Bone
9.1 Skin, Soft Tissue, and Bone Pathogens 9.2 Bite Wounds and Zoonotic Infections 9.3 SST Pathogenicity and Virulence Mechanisms
10 Bacteriology: Genital Tract and Urine
10.1 Genital Flora and Vaginitis Pathogens 10.2 Neisseria gonorrhoeae, Chlamydia trachomatis, GBS, and Mycoplasma 10.3 Urinary Pathogens, Colony Counts, and Urinalysis Correlation
11 Bacteriology: Identification Methods
11.1 Colony Morphology and Rapid Presumptive Tests 11.2 Conventional Biochemicals and Commercial Kits 11.3 Automated Methods, MALDI-TOF MS, Molecular, and 16S Sequencing
12 Bacteriology: Antimicrobial Susceptibility and Resistance
12.1 Microbroth Dilution, Disk Diffusion, and Gradient Diffusion 12.2 Phenotypic Detection of Resistance 12.3 Antibiotic Classes, Intrinsic Resistance, and Genetic Markers
13 Bacteriology: Resistance Screening and Select Agents
13.1 MRSA/MSSA, VRE, ESBL/CRE Screening 13.2 BSL-3 Pathogens and Select-Agent Presumptive Identification 13.3 Laboratory Response Network and Select-Agent Pathogenicity
14 Mycobacteriology and Nocardia
14.1 Specimens, Major Pathogens, and Disease States 14.2 Acid-Fast Reaction, Colony Morphology, and Growth Characteristics 14.3 Identification Methods, Direct Molecular Detection, and TB Therapy
15 Virology
15.1 Respiratory, Vesicle, Meningitis, and GI Viruses 15.2 Hepatitis, HIV, and Immunocompromised-Host Viruses 15.3 Direct Detection Methods and HPV Cervical Screening
16 Parasitology
16.1 Blood, Tissue, and Brain Protozoa 16.2 Intestinal/Urogenital Protozoa and Helminths 16.3 Microscopy, Antigen/Molecular Detection, Insects and Arthropods
17 Mycology
17.1 Yeasts: Candida, Cryptococcus, and Malassezia 17.2 Dimorphic Fungi and Dermatophytes 17.3 Mucorales, Hyaline Molds, Pneumocystis, and Identification Methods
18 Serology
18.1 Immunoglobulin Response and Antigen-Antibody Methods 18.2 Viral Serodiagnosis: Hepatitis, EBV, HIV, CMV, Rubella, Measles 18.3 Treponema, Borrelia, and TB Infection Serodiagnosis
19 Laboratory Operations: Postanalytic Procedures and Quality
19.1 Documentation, Critical Values, Corrected Reports, and Public Health 19.2 Quality Control, Root-Cause Analysis, and POCT 19.3 Proficiency Testing, Competency, and Accreditation
20 Laboratory Operations: Safety, Mathematics, and Instrumentation
20.1 Biosafety, PPE, Bloodborne Pathogens, and SDS 20.2 Emergencies and Packaging/Transportation of Specimens 20.3 Laboratory Mathematics and Instrumentation
19.3 Proficiency Testing, Competency, and Accreditation
Key Takeaways Explain This Topic AI
Treat PT samples like patient specimens: same method, same staff rotation, no extra send-out identification used only to improve the PT score.
Do not discuss PT content with another laboratory or refer PT for the intended answer; mixed or unlike-patient handling can leave the event ungraded and can violate CLIA.
Competency for nonwaived testing uses the applicable CLIA methods (direct observation, record monitoring, QC/PT/maintenance review, instrument-maintenance observation, unknowns/PT, and problem solving) at 6 months and 12 months in the first year, then annually.
Most routine microbiology culture, identification, and AST is CLIA high-complexity; waived rapid antigen kits do not make the culture bench waived.
CLIA is the federal floor; CAP and The Joint Commission are CMS-approved accreditors—learn the concepts, not invented checklist numbers.
Last updated: August 2026
19.3 Proficiency Testing, Competency, and Accreditation
Quick Answer: Treat PT like a patient specimen: same method, same staff rotation, no phone-a-friend to another lab, no referral for the "real" ID. Mixed or unlike-patient handling can make the event ungraded and can violate CLIA. Competency for nonwaived testing uses the applicable CLIA methods—direct observation, record review, QC/PT/maintenance review, instrument maintenance observation, unknowns/PT, and problem solving—at 6 months and 12 months in the first year of testing, then annually. Most microbiology culture, identification, and AST is high-complexity under CLIA; CAP and The Joint Commission inspect many labs as CMS-approved accreditors.
Outline IV.B.5 Regulations (guideline 2025-09-25 ) names proficiency testing, competency assessment, and accreditation standards. IV.F Laboratory Administration is SM-only and is not an M management-theory section. This page is the federal floor a bench scientist has to live inside.
Proficiency testing
Proficiency testing (PT) is an external check that the laboratory's method, as used on patients, can still identify or measure the challenge. CMS/CLIA requires enrollment in approved PT for regulated nonwaived testing. Microbiology challenges include organism identification, stains, AST, antigen or NAAT methods, and parasite or mycology slides, depending on the menu. Most specialties are challenged in three events per year .
Treat PT like patient specimens. The people who routinely perform the test perform the PT. Use the same SOP, media, instruments, and stain or dilution technique. Do not reserve PT for the supervisor. Do not run extra biochemicals or send-out sequencing that you would not use for a similar patient isolate. Do not test PT after hours with a selected "dream team."
No interlaboratory communication about PT content or intended results before the reporting deadline. Calling a sister hospital, a former classmate, or the state laboratory to confirm the identification is prohibited. Do not refer a PT sample to another laboratory to obtain the PT answer. Even if a comparable patient isolate would be referred, you may not ship the PT challenge to harvest a program score. If a PT sample is mixed into another laboratory's work , identified collaboratively across institutions, or handled unlike patients, the event may be ungraded and can count as unsuccessful participation or as illegal PT referral. Repeated unsuccessful PT can force a laboratory to stop testing that analyte.
Failed or unsatisfactory PT is an RCA event (19.2): investigate, corrective action, possibly cease reporting until competency and QC are shown, and document. Never invent a matching answer after the intended result is posted. Sign the attestation that PT was handled like patient testing.
- PT rule Required practice Exam trap
- Same as patients Routine staff, method, and workflow Supervisor-only or extra send-out ID
- No communication No calls or texts to another lab about the challenge "Just confirming the Gram morphology"
- No referral Do not ship PT for the program answer "We refer hard isolates anyway"
- Mixed handling Risk of ungraded event and CLIA violation Splitting the sample with a neighboring hospital
Failure Investigate, correct, document; may pause testing Changing the submitted answer after the key is posted
Competency assessment
CLIA requires competency assessment of personnel who perform nonwaived (moderate- and high-complexity) testing. Frequency: at 6 months after the person begins patient testing and again by 12 months in that first year, then at least annually . A new method restarts competency for that method.
Use each CLIA method that applies to the test system. Exams list them as a set; not every element applies to a fully manual wet mount:
- Direct observation of routine test performance
- Monitoring recording and reporting of results
- Review of intermediate results, QC records, PT, and preventive maintenance
- Direct observation of instrument maintenance and function checks
- Assessment of test performance with previously analyzed specimens, internal blinds, or PT/unknowns
- Assessment of problem-solving skills
Waived POCT competency is still required by the laboratory SOP and by accreditors even though CMS writes the six-element list for nonwaived testing; observation plus QC and problem-solving is the practical minimum on M items about rapid flu or strep operators. A hire-day quiz with no observation does not satisfy the 6-month or annual requirement. Watching a vendor video is training, not competency. Department-level PT does not replace individual observation and problem-solving for each testing person.
Accreditation standards and complexity
CLIA (Clinical Laboratory Improvement Amendments), administered by CMS , is the U.S. federal law. Certificate types include waiver, provider-performed microscopy, compliance (CMS inspection), and accreditation (inspection by a CMS-approved organization). Regulatory items on M use U.S. sources .
CAP (College of American Pathologists) and The Joint Commission are the named accreditors on most exam stems. They have deemed status : their inspection can satisfy CLIA if the laboratory holds the corresponding CLIA certificate of accreditation. Do not memorize a fabricated CAP checklist number. The exam wants the concept —document control, QC, PT, competency, safety, reporting—not a citation such as a made-up "MIC" clause.
Complexity drives personnel, QC, PT, and competency. Most routine microbiology culture, identification, and AST is high-complexity. Mycobacteriology, mycology culture, and parasitology microscopy are high-complexity. Many rapid antigen kits (strep, influenza, COVID-19) are waived only if used exactly as the manufacturer wrote. Some cartridge molecular tests are moderate complexity. A waived throat swab does not convert the blood-culture bench into waived testing. A volunteer cannot be handed plates because "it is just streaking."
Personnel who perform high-complexity testing must meet CLIA high-complexity qualifications. M does not ask you to recite a CFR paragraph, but it does ask who may release high-complexity results and whether a method is waived. When a stem names CAP or The Joint Commission, the operational answer still matches CLIA: PT like patients, competency on a calendar, QC in control, critical results called and documented. Accreditation is how many hospital laboratories prove CLIA compliance; it is not a different biology.
- Exam traps
- Sending PT to the reference laboratory "the way hard isolates go."
Texting a friend at another hospital the PT Gram morphology.
One written test at hire as the only competency for a year.
Calling bacterial culture waived because a rapid strep kit is waived.
Quoting an invented CAP checklist number as if it were the answer.
Regulations exist so the organism name in 19.1 is defensible. Drill PT-and-competency stems in the free ASCP M practice bank .